Dysregulated expression and glycosylation of MUC1 and MUC16 in cancer, notably affecting immune modulation and metastasis, impair dendritic cell function, resulting in heightened immunosuppression and advancing tumor progression (7). The gene discussed is MUC1; the disease is neoplasm.